Frequency and Distribution of Mixed Falciparum-vivax Infections in French Guiana
NCT02903758 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2016-09-16
Summary
Malaria is still endemic in the interior of French Guiana. mixed infections by 2 or more different malaria parasites lead to complex and potentially harmfull therapeutic problems. The aim of the study was to look at malaria smears between 2000 and 2008 and determine using PCR the frequency of mixed infections, and their distribution in the terrtory of French Guiana. Overall 10.75% of 400 smears showed mixed infection with P. falciparum and P. vivax. The Maroni river where Duffy negative populations live was largely devoid of vivax infections. These results suggest that mixed infections are frequent in french guiana except on the Maroni river which leads to practical implications for clinicians facing a patient with clinical malaria.
Conditions
Interventions
- OTHER
-
cross sectional
Sponsors & Collaborators
-
universite de guyane
collaborator UNKNOWN -
Centre Hospitalier de Cayenne
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-31
- Primary Completion
- 2000-01-31
- Completion
- 2008-12-31
Countries
- France
More Related Trials
-
Treatment of Non-falciparum Malaria
NCT00725777 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the Congo
NCT02940756 ·Status: COMPLETED ·Phase: PHASE4
-
Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria
NCT02528279 ·Status: COMPLETED ·Phase: NA
-
Clinical Practices for Treating Severe Malaria Caused by P. Falciparum
NCT07027722 ·Status: COMPLETED
-
Transmission Dynamics of Residual and Re-emerging Malaria in the Amazon: Defining a Roadmap to Malaria Elimination
NCT03689036 ·Status: UNKNOWN
-
Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, Indonesia
NCT02325180 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Preliminary Protective Efficacy of Genetically Attenuated GA2 Parasites.
NCT04577066 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SP Resistance and Falciparum Malaria Transmission
NCT00299247 ·Status: WITHDRAWN ·Phase: PHASE3
-
Cohort Event Monitoring Study of Pyramax®
NCT03201770 ·Status: COMPLETED ·Phase: PHASE4
-
P. Falciparum Infection Dynamics and Transmission to Inform Elimination
NCT04053907 ·Status: UNKNOWN ·Phase: NA
-
Combination Antimalarials in Uncomplicated Malaria
NCT00203801 ·Status: COMPLETED ·Phase: NA
-
P. Falciparum Infection Dynamics and Transmission to Inform Elimination (INDIE-1a)
NCT03705624 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum
NCT02488902 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel Sites
NCT05070520 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines
NCT00229775 ·Status: COMPLETED ·Phase: NA
-
Effect of Antimalarial Treatment on Gametocyte Carriage in Asymptomatic P. Falciparum
NCT00289250 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo
NCT04618523 ·Status: COMPLETED ·Phase: PHASE4
-
Malaria in Early Life Study
NCT02001428 ·Status: COMPLETED ·Phase: NA
-
Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers
NCT01838902 ·Status: COMPLETED ·Phase: PHASE3
-
Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum Transmission
NCT04049916 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Trial of Malaria Seasonal IPTc Combined With Community Case Management
NCT01449045 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Malaria Treatment in Mexico
NCT02394197 ·Status: COMPLETED ·Phase: PHASE4
-
Controlled Human Malaria Infection After Bites From Mosquitoes Infected With Two Novel P. Falciparum Strains
NCT02149550 ·Status: COMPLETED ·Phase: NA
-
Severe Malaria in Remote Areas- Closing the Evidence Gap
NCT06806956 ·Status: ENROLLING_BY_INVITATION
-
The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy
NCT01906788 ·Status: UNKNOWN ·Phase: PHASE4